Total Payments
$294.05
2024 Payments
$33.01
Companies
6
Transactions
14
Medicare Patients
6,483
Medicare Billing
$278,703
Payment Breakdown by Category
Food & Beverage$294.05 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $294.05 | 14 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Genentech USA, Inc. | $104.68 | 5 | $0 (2021) |
| Relievant Medsystems, Inc. | $81.10 | 2 | $0 (2023) |
| Collegium Pharmaceutical, Inc. | $48.39 | 3 | $0 (2024) |
| Egalet US Inc | $27.23 | 2 | $0 (2017) |
| GlaxoSmithKline, LLC. | $17.20 | 1 | $0 (2024) |
| Lupin Inc. | $15.45 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $33.01 | 2 | GlaxoSmithKline, LLC. ($17.20) |
| 2023 | $113.68 | 4 | Relievant Medsystems, Inc. ($81.10) |
| 2021 | $21.59 | 1 | Genentech USA, Inc. ($21.59) |
| 2019 | $83.09 | 4 | Genentech USA, Inc. ($83.09) |
| 2018 | $15.45 | 1 | Lupin Inc. ($15.45) |
| 2017 | $27.23 | 2 | Egalet US Inc ($27.23) |
All Payment Transactions
14 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/07/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: RESPIRATORY | ||||||
| 03/19/2024 | Collegium Pharmaceutical, Inc. | Belbuca (Drug) | Food and Beverage | Cash or cash equivalent | $15.81 | General |
| Category: Opioid Analgesic | ||||||
| 07/25/2023 | Relievant Medsystems, Inc. | Intracept (Device), Intracept, Intracept | Food and Beverage | Cash or cash equivalent | $64.60 | General |
| Category: Pain | ||||||
| 07/25/2023 | Relievant Medsystems, Inc. | Intracept (Device), Intracept, Intracept | Food and Beverage | Cash or cash equivalent | $16.50 | General |
| Category: Pain | ||||||
| 07/24/2023 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $16.58 | General |
| Category: Opioid Analgesic | ||||||
| 05/24/2023 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $16.00 | General |
| Category: Opioid Analgesic | ||||||
| 02/12/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $21.59 | General |
| Category: Virology & Specialty Care | ||||||
| 12/23/2019 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $21.89 | General |
| Category: Virology & Specialty Care | ||||||
| 12/06/2019 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: Virology & Specialty Care | ||||||
| 11/07/2019 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: Virology & Specialty Care | ||||||
| 10/30/2019 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $15.59 | General |
| Category: Virology & Specialty Care | ||||||
| 06/27/2018 | Lupin Inc. | SUPRAX (Drug) | Food and Beverage | In-kind items and services | $15.45 | General |
| Category: INFECTIONS AND INFECTIOUS DISEASES | ||||||
| 07/14/2017 | Egalet US Inc | SPRIX (Drug) | Food and Beverage | In-kind items and services | $12.05 | General |
| Category: Pain Medicine | ||||||
| 05/23/2017 | Egalet US Inc | SPRIX (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: Pain Medicine | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 686 | 1,100 | $95,677 | $47,525 |
| 2022 | 30 | 2,046 | 4,123 | $226,565 | $83,289 |
| 2021 | 33 | 2,364 | 4,931 | $263,151 | $100,524 |
| 2020 | 26 | 1,387 | 3,138 | $156,490 | $47,366 |
Total Patients
6,483
Total Services
13,292
Medicare Billing
$278,703
Procedure Codes
97
All Medicare Procedures & Services
97 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 286 | 474 | $40,290 | $21,410 | 53.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 197 | 229 | $29,770 | $15,939 | 53.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 46 | 46 | $7,590 | $4,216 | 55.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 54 | 55 | $10,774 | $3,790 | 35.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 31 | 31 | $3,410 | $1,736 | 50.9% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 35 | 52 | $2,184 | $402.47 | 18.4% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 17 | 68 | $1,224 | $23.46 | 1.9% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 20 | 145 | $435.00 | $9.72 | 2.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 368 | 437 | $84,778 | $39,428 | 46.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 108 | 108 | $32,184 | $12,584 | 39.1% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2022 | 174 | 183 | $18,300 | $6,335 | 34.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 57 | 60 | $7,500 | $4,160 | 55.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 255 | 423 | $17,766 | $3,642 | 20.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 27 | 28 | $7,280 | $3,495 | 48.0% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2022 | 79 | 162 | $6,156 | $2,606 | 42.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 12 | 12 | $4,476 | $2,046 | 45.7% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 77 | 79 | $6,455 | $1,689 | 26.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 15 | 15 | $2,895 | $1,272 | 43.9% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 70 | 80 | $2,240 | $835.76 | 37.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 72 | 81 | $2,025 | $622.17 | 30.7% |
| 73630 | X-ray of foot, minimum of 3 views | Office | 2022 | 21 | 22 | $1,936 | $516.05 | 26.7% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2022 | 30 | 30 | $1,104 | $474.68 | 43.0% |
| 73110 | X-ray of wrist, minimum of 3 views | Office | 2022 | 15 | 16 | $1,408 | $451.69 | 32.1% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 30 | 33 | $990.00 | $437.19 | 44.2% |
| 73562 | X-ray of knee, 3 views | Office | 2022 | 15 | 16 | $1,360 | $423.68 | 31.2% |
About Dr. Audra Busenlehner, M.D
Dr. Audra Busenlehner, M.D is a Family Medicine healthcare provider based in Northport, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1720051584.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Audra Busenlehner, M.D has received a total of $294.05 in payments from pharmaceutical and medical device companies, with $33.01 received in 2024. These payments were reported across 14 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($294.05).
As a Medicare-enrolled provider, Busenlehner has provided services to 6,483 Medicare beneficiaries, totaling 13,292 services with total Medicare billing of $278,703. Data is available for 4 years (2020–2023), covering 97 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Northport, AL
- Active Since 02/10/2006
- Last Updated 05/30/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1720051584
Products in Payments
- Xofluza (Drug) $104.68
- Intracept (Device) $81.10
- XTAMPZA (Drug) $32.58
- SPRIX (Drug) $27.23
- AREXVY (Drug) $17.20
- Belbuca (Drug) $15.81
- SUPRAX (Drug) $15.45
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Northport
Clinton Mcentyre, M.d, M.D
Family Medicine — Payments: $20,557
Family Medicine $20,557
Scott Kemp, D.o, D.O
Family Medicine — Payments: $19,805
Family Medicine $19,805
Dr. Malika Aryanpure, M.d, M.D
Family Medicine — Payments: $10,105
Family Medicine $10,105
Dr. Caroline Day, Md, MD
Family Medicine — Payments: $10,016
Family Medicine $10,016
Ronald Harrison, Do, DO
Family Medicine — Payments: $7,099
Family Medicine $7,099
Steven Coppock, M.d, M.D
Family Medicine — Payments: $6,510
Family Medicine $6,510